Opioid

McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
Publicis To Pay $350M In First-Ever Opioid Marketing Settlement
This New Fentanyl Overdose-Reversal Drug Is Stronger Than Narcan: Here's Why
Publicis To Pay $350M In First-Ever Opioid Marketing Settlement
This New Fentanyl Overdose-Reversal Drug Is Stronger Than Narcan: Here's Why
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters

Opioid Recent News

New York City First In The U.S. To Open Safe Injection Sites For Illegal Drugs In Effort To Stem Overdose Crisis
On Tuesday, New York City became the first in the nation to open two overdose prevention centers (OPC) where people can use illicit drugs and receive medical care and services.
US Jury Finds Pharmacy Chains Did Not Monitor Opioid Usage, Thus Fueling Epidemic: Reuters
Jurors in Cleveland federal court have determined that pharmacy chain operators CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE:
New Study Links Psychedelic Use With 55% Decrease In Daily Opioid Use
Psychedelic use may provide a window of opportunity to kick drug addiction, according to a recent study.
SI-BONE's Sacroiliac Joint Implant Show Accelerated Fusion, Reduction In Opioid Use
BioXcel Stock Is Trading Lower After BXCL501 Data In Opioid Withdrawal Study
How MindMed Uses Tech To Innovate, Deploy Psychedelic Mental Health Therapies
In an exclusive to Benzinga, Mind Medicine (MindMed) Inc (OTC: MMEDF), a leading medicine biotech company in psychedelics, on Tuesday revealed the introduction of a division known as Albert, to help research and develop an integrated platform for delivering psychedelic medicines, experiential therapies,
Canada Health Minister Calls To Keep Injectable Opioid Therapy Treatment Program In Alberta Open
This article was originally published on Microdose Psychedelic Insights, and appears here with permission.
Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates
Adamis Pharma's Monday Morning Rally: What You Need To Know
Exclusive: Recro Pharma CEO Talks Non-Opioid Pain Management Opportunity, CDMO Business
Piper Jaffray Loses Confidence In Insys Therapeutics, Downgrades Stock
Insys Accepts Founder Kapoor's Resignation, Preps $150 Million To Settle Dept. Of Justice Investigation
A Look At Opiant Pharmaceuticals, The Stock That Skyrocketed On Trump's Opioid Declaration
22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency
John Kapoor, Founder Of Insys, Indicted On Charges Of Bribing Doctors To Overprescribe Opioids
Valeant's CEO Details The Company's 'Great Progress' And What's Next
How Marijuana Can Help Treat Addictions To Opioids, Other Rx Drugs And Alcohol
Alkermes Looks To Capitalize On Opioid Epidemic Through Aggressive Lobbying
Endo To Enter A Year Of Recovery Following FDA Request To Pull OPANA ER Off The Market
DoJ Takes Action On Insys For 'Unfair, Deceptive Marketing Practices' Of Fentanyl Drug
Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients
Facebook Is Addictive, But Now It's Being Used To Treat Addicts